Source:http://linkedlifedata.com/resource/pubmed/id/19258424
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-3-16
|
pubmed:abstractText |
Piceatannol is a naturally occurring bioactive stilbene with documented antileukemic properties. It has been extensively used as a Syk-selective protein tyrosine kinase inhibitor for the study of various signaling pathways. Herein, we show that the hydroxystilbene, piceatannol, and related catechol ring-containing compounds are able to induce the loss of the Cbl family of proteins. Normal cellular Cbl-regulatory mechanisms were not involved in this process. Screening of a small library of piceatannol-like compounds indicated that aromaticity and a catechol ring were required for the induction of Cbl loss. Further examination of these two chemical properties showed that the oxidative conversion of the catechol ring of piceatannol into a highly reactive O-benzoquinone was the cause of piceatannol-induced Cbl loss. Characterization of the Cbl selectivity of piceatannol-induced protein loss revealed that this compound was also able to induce the functional loss of specific Cbl-associated proteins involved in signaling pathways commonly associated with cancer. This work uncovers a new, piceatannol-dependent effect and shows a novel way in which this phenomenon can be exploited to inhibit disease-associated signaling pathways.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3,3',4,5'-tetrahydroxystilbene,
http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic,
http://linkedlifedata.com/resource/pubmed/chemical/CBLB protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-cbl,
http://linkedlifedata.com/resource/pubmed/chemical/Stilbenes
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1535-7163
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
602-14
|
pubmed:meshHeading |
pubmed-meshheading:19258424-3T3 Cells,
pubmed-meshheading:19258424-Adaptor Proteins, Signal Transducing,
pubmed-meshheading:19258424-Animals,
pubmed-meshheading:19258424-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:19258424-Cells, Cultured,
pubmed-meshheading:19258424-Humans,
pubmed-meshheading:19258424-K562 Cells,
pubmed-meshheading:19258424-Mice,
pubmed-meshheading:19258424-Models, Biological,
pubmed-meshheading:19258424-Neoplasms,
pubmed-meshheading:19258424-Oxidation-Reduction,
pubmed-meshheading:19258424-Protein Binding,
pubmed-meshheading:19258424-Protein Processing, Post-Translational,
pubmed-meshheading:19258424-Proto-Oncogene Proteins c-cbl,
pubmed-meshheading:19258424-Signal Transduction,
pubmed-meshheading:19258424-Stilbenes
|
pubmed:year |
2009
|
pubmed:articleTitle |
The phytochemical piceatannol induces the loss of CBL and CBL-associated proteins.
|
pubmed:affiliation |
Southern Alberta Cancer Research Institute, Department of Oncology, The University of Calgary, 3330 Hospital Drive Northwest, Calgary, Alberta, Canada T2N-4N1.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|